Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

Completed

Conditions studied: Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage II Prostate Cancer, Stage III Prostate Cancer

In brief

The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.

Key facts

Study ID

NCT03963739

Run by

Wake Forest University Health Sciences

People needed

255

Starts

2019-07-19

Expected to finish

2025-03-25

Last updated by the study team

2025-07-16

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male diagnosed with adenocarcinoma of the prostate, stage I, II, or III. Patient may have already received hormonal therapy or expect to receive hormonal therapy as treatment for adenocarcinoma of the prostate
• Scheduled to undergo prostatectomy or initiate radiation for primary curative treatment of adenocarcinoma of the prostate within 90 days of enrollment
• Self-identify as African American/black, non-Hispanic OR white, non-Hispanic; Participants are considered African American for recruitment purposes if they (1) identify solely as African American for race OR (2) identify as African American and white for race, but do not identify as also being of another race. Participants are considered white for recruitment purposes if they select white and no other race. (These identities are based on participant self-report during the screening process.)
• Eastern Cooperative Oncology Group (ECOG) score = 0 or 1
• Worked within the past 14 days prior to screening (no minimum number of hours required) OR (a) worked at some point between March 1, 2020 - March 14, 2020 and (b) subsequently lost job involuntarily due to COVID-19.
• Intends to be working 6 months from screening (if opportunity to work is available pending the COVID-19 pandemic considerations)
• Patient is willing to provide answers on the patient eligibility questionnaire regarding household income
• Age at time of screening is > or = 18
• Can speak and understand spoken English
• Ability to understand an informed consent document (even if only verbally) and willingness to agree to informed consent document
• Access to telephone or willingness to travel to National Cancer Institute (NCI) Community Oncology Research Program (NCORP) site for each of the three interviewer-administered structured questionnaires
• Able to hear sufficiently to understand a conversation determined by a simple test given at screening
• Has not previously had a prostatectomy, radiation therapy, or chemotherapy to treat adenocarcinoma of the prostate
• Not expected (at time of screening) to receive chemotherapy for primary treatment of adenocarcinoma of the prostate

You may not qualify if…

• Patient has received therapy for any other cancer within last 3 years (except for non-melanoma skin cancer)
• Patient plans to receive therapy for any other cancer within the next year (except for non-melanoma skin cancer)

Where it is running

• Mercy Hospital Fort Smith — Fort Smith, Arkansas, United States
• CHI Saint Vincent Cancer Center Hot Springs — Hot Springs, Arkansas, United States
• Kaiser Permanente-Anaheim — Anaheim, California, United States
• Mission Hope Medical Oncology - Arroyo Grande — Arroyo Grande, California, United States
• Kaiser Permanente-Baldwin Park — Baldwin Park, California, United States
• Kaiser Permanente-Bellflower — Bellflower, California, United States
• Kaiser Permanente-Fontana — Fontana, California, United States
• Kaiser Permanente-Irvine — Irvine, California, United States
• Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States
• Kaiser Permanente West Los Angeles — Los Angeles, California, United States
• Kaiser Permanente-Ontario — Ontario, California, United States
• Mission Hope Medical Oncology - Santa Maria — Santa Maria, California, United States
• Penrose-Saint Francis Healthcare — Colorado Springs, Colorado, United States
• Rocky Mountain Cancer Centers-Penrose — Colorado Springs, Colorado, United States
• Saint Francis Cancer Center — Colorado Springs, Colorado, United States
• Porter Adventist Hospital — Denver, Colorado, United States
• Mercy Medical Center — Durango, Colorado, United States
• Southwest Oncology PC — Durango, Colorado, United States
• Saint Anthony Hospital — Lakewood, Colorado, United States
• Littleton Adventist Hospital — Littleton, Colorado, United States
• Longmont United Hospital — Longmont, Colorado, United States
• Rocky Mountain Cancer Centers-Longmont — Longmont, Colorado, United States
• Parker Adventist Hospital — Parker, Colorado, United States
• Saint Mary Corwin Medical Center — Pueblo, Colorado, United States
• Cancer Center at Saint Joseph's — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.